If approved by the FDA, tavapadon would be the first new dopamine agonist for Parkinson's disease in decades. What does the ...
Parkinson’s disease is caused by decreased dopamine activity in a brain region. It often has no identifiable trigger, but ...
Medically reviewed by Huma Sheikh, MD Key Takeaways Parkinson’s is a neurological movement disorder caused by environmental and genetic factors that change the brain’s chemical makeup.Parkinson’s can ...
Contrast sensitivity in patients with Parkinson’s disease was significantly worse across lighting conditions, pointing to the ...
Experts speaking to the Mail have revealed we are on the cusp of a revolution in Parkinson's treatment, with a new generation ...
A new study by investigators from the Mass General Brigham Neuroscience Institute has identified common genetic variants in ...
Carbon monoxide may help explain the long-observed but perplexing association between smoking and a lower risk for ...
Barry Melrose, a former NHL coach and longtime ESPN analyst, has died following a battle with Parkinson’s disease. He was 70.
Parkinson’s disease is significantly less common among people who smoke cigarettes. It’s a paradox that has perplexed ...